Idebenone and TRP-2 mRNA Lipid Nanoparticles Show Promise in Melanoma
An October 2026 JID supplement abstract reports idebenone plus TRP-2 mRNA lipid nanoparticles enhanced dendritic-cell activation and anti-tumor immunity in melanoma.
Topic
Mrna Therapy
Topic
Mrna Therapy
AI-Designed Personalized mRNA Therapy Cuts Melanoma Recurrence Risk
An AI-designed personalized mRNA therapy has reduced melanoma recurrence, metastasis and death, BioXconomy reports; effect sizes…
Merck Reports First Positive Phase 3 for Personalized mRNA Melanoma Therapy
Merck posts the first positive Phase 3 result for a personalized mRNA melanoma therapy, advancing individualized neoantigen immun…
mRNA Drug Shows Breakthrough Potential in Deadly Skin Cancer
An experimental mRNA drug has shown breakthrough potential against deadly skin cancer, extending messenger RNA technology from va…
Melanoma Vaccine Candidate Shows Promise: What Dermatologists Know
A personalized mRNA melanoma vaccine cut recurrence or death risk by 44% versus pembrolizumab alone in phase 2b; phase 3 results…